Pathologic Complete Response: all 138 studies
Page 1 of 2. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.
- Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective StudyRecruitingNCT07878364
- SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete ResponseNot yet recruitingNCT07856303Phase 2
- Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)RecruitingNCT07855926
- Perioperative Adebrelimab for Locally Advanced Cervical CancerNot yet recruitingNCT07811375Phase 2
- Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With Chemoimmunotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma：A Prospective Single-Arm, Phase II StudyRecruitingNCT07808853Phase 2
- Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck CancerNot yet recruitingNCT07780877Phase 2
- Supervised Exercise During Neoadjuvant Chemotherapy for Breast CancerNot yet recruitingNCT07764341Not applicable
- Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCRecruitingNCT07754812Phase 4
- Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal CarcinomaNot yet recruitingNCT07752394Phase 2
- Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical CancerNot yet recruitingNCT07673211
- Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell CarcinomaNot yet recruitingNCT07618793Phase 2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 2
- Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal CarcinomaNot yet recruitingNCT07538206Phase 1/2
- Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal CancerRecruitingNCT07472868Phase 3
- Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell CarcinomaRecruitingNCT07430579Not applicable
- NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUCNot yet recruitingNCT07412171Phase 2
- Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal CancerNot yet recruitingNCT07397442Phase 2
- T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CRRecruitingNCT07353840
- Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar CancerRecruitingNCT07353723Phase 2
- 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal CarcinomaRecruitingNCT07328854Phase 3
- Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and ImmunotherapyRecruitingNCT07328841Phase 3
- Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast CancerRecruitingNCT07166185
- Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast CancerNot yet recruitingNCT07164872Not applicable
- Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBCRecruitingNCT07066189Not applicable
- Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm PatientsRecruitingNCT07007052Phase 2
- SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT06927180Phase 2
- Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant TherapyNot yet recruitingNCT06889402
- Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCRecruitingNCT06811844Phase 2
- Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell CarcinomaRecruitingNCT06755567
- Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot StudyNot yet recruitingNCT06743555Phase 1
- Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）RecruitingNCT06647680Phase 2
- Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal CancerRecruitingNCT06364371
- Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast CancerRecruitingNCT06276868Phase 2
- The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPCRecruitingNCT06182657
- Relugolix + Enzalutamide Study in High-Risk Prostate CancerRecruitingNCT06130995Phase 1
- Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLCRecruitingNCT06111807
- Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer PatientsRecruitingNCT05976815Not applicable
- Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung CancerRecruitingNCT05925751
- Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT05918328Phase 2
- Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 TrialRecruitingNCT05763992Phase 2
- Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue SarcomaRecruitingNCT05684874Not applicable
- Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast CancerRecruitingNCT05659056Phase 2
- Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas AeruginosaRecruitingNCT05642767
- DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic TherapyRecruitingNCT05416164Not applicable
- Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer PatientsRecruitingNCT05350722Not applicable
- Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and WaitRecruitingNCT05000697Not applicable
- Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal CancerRecruitingNCT04743102Not applicable
- Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia PatientsRecruitingNCT04314219Phase 3
- Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)RecruitingNCT04293796Not applicable
- Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant ChemotherapyNot yet recruitingNCT04225858Not applicable
- Phase I Study of KN044 in Locally Advanced/Metastatic Solid TumorsRecruitingNCT04126590Phase 1
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable
- "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal CancerRecruitingNCT03426397
- Watch and Wait as Treatment for Patients With Rectal CancerRecruitingNCT03125343Not applicable
- Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.RecruitingNCT02907827Not applicable
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingNCT01042379Phase 2
- Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.CompletedNCT06996301Not applicableResults posted
- A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)TerminatedNCT04934670Phase 3Results posted
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based ChemotherapyActive, not recruitingNCT03522246Phase 3Results posted
- Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC PatientsCompletedNCT01934452Results posted
- Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.Active, not recruitingNCT01844986Phase 3Results posted
- Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma RelapseTerminatedNCT01794572Not applicableResults posted
- Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete RemissionCompletedNCT01757535Phase 3Results posted
- Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete RemissionTerminatedNCT01656252Phase 1/2Results posted
- CNDO-109-AANK for AML in First Complete Remission (CR1)Status unknownNCT01520558Phase 1/2Results posted
- Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)CompletedNCT01392183Phase 2Results posted
- WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)CompletedNCT01266083Phase 2Results posted
- Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)CompletedNCT00725283Phase 1Results posted
- Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerTerminatedNCT00636441Phase 2Results posted
- Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell CarcinomaCompletedNCT06854107
- Study on the Applicability of CCR Criteria in Rectal CancerCompletedNCT06794099
- Impact Of Metformin In Rectal Cancer PatientsCompletedNCT06728982Phase 2/3
- Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT06694454Phase 1/2
- Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) PatientsWithdrawnNCT06180863Phase 2
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruitingNCT06087718Not applicable
- Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary TreatmentActive, not recruitingNCT05926024
- PIK3CA in HER2+ BC and pCR TrialStatus unknownNCT05750693Not applicable
- Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal CancerCompletedNCT05534841
- Stool and Serum CMV-PCR in Diagnosing CMV ColitisCompletedNCT05522283
- A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast CancerWithdrawnNCT05474690Phase 3
- Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI TechnologyStatus unknownNCT05441098
- Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete ResponseWithdrawnNCT05371860Phase 2
- Pilot Study of Tocilizumab Monotherapy for Active Chronic PeriaortitisCompletedNCT05133895
- PTC Guiding Neoadjuvant Treatment in Breast CancerCompletedNCT05103293Phase 2
- Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast NeoplasiaStatus unknownNCT05050890
- CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic ProphylaxisCompletedNCT05005169Not applicable
- TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal CancerCompletedNCT04939103
- IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.Status unknownNCT04917263
- INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast CancerStatus unknownNCT04781725Phase 2
- Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19Status unknownNCT04603794Phase 4
- FREEDOM COVID-19 Anticoagulation StrategyCompletedNCT04512079Phase 4
- CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NACStatus unknownNCT04457700
- Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT04435197Phase 2
- NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 3
- Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal CancerStatus unknownNCT04278274
- Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal CancerStatus unknownNCT04273477
- RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal CancerCompletedNCT04271657
- Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2Active, not recruitingNCT04229979Phase 3
- Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal CancerStatus unknownNCT04006041Phase 2